Lipids

Impairments
  • Awaiting additional investigation or testing
  • Congestive Heart Failure (CHF)
  • Ejection Fraction below 35% (as measured by most recent evaluation)
  • Poor compliance with treatment and/or follow-up
  • Severe aortic or mitral valve disease
  • Ventricular Dysfunction, either systolic or diastolic, described as “moderate” or “severe”